Literature DB >> 3486823

Effect of PHA-activated T cells on B-cell differentiation.

B Gansbacher, A I Levinson.   

Abstract

Recent studies indicate that human T cells expressing the T4 determinant are comprised of functionally distinct subsets. We investigated if activation of OKT4+ cells with the mitogen PHA affected their ability to regulate the proliferation and polyclonal differentiation of autologous B cells. OKT4+ cells were preactivated with PHA and then cocultured with autologous B cells in the presence or absence of PWM. B-cell proliferation and differentiation to immunoglobulin-secreting cells (IgSC) were assessed by [3H]thymidine incorporation and reverse haemolytic plaque assay, respectively. In the absence of PWM, the PHA-activated OKT4+ cells demonstrated radioresistant help and radiosensitive suppression of IgSC responses. Addition of PWM to cocultures of irradiated PHA preactivated OKT4 cells and autologous B cells resulted in further suppression of IgSC responses, suggesting that PWM activated yet another suppression mechanism. Addition of PWM caused diminished B-cell proliferation as well. These data demonstrate functional heterogeneity within the OKT4 subset, and suggest that the particular immunoregulatory activity displayed is influenced by the state and mode of activation of these cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486823      PMCID: PMC1452652     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.

Authors:  Y Thomas; L Rogozinski; L Rabbani; A Chess; G Goldstein; L Chess
Journal:  J Mol Cell Immunol       Date:  1984

2.  Specificity spectrum and cell surface markers of mono- and multi-functional mixed leukocyte culture-derived T cell clones in man.

Authors:  G Pawelec; P Kahle; P Wernet
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

3.  Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; H H Shen; M A Talle; G Goldstein; L Chess
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

4.  Staphylococcal peptidoglycan: T-cell-dependent mitogen and relatively T-cell-independent polyclonal B-cell activator of human lymphocytes.

Authors:  A I Levinson; A Dziarski; B Zweiman; R Dziarski
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma.

Authors:  Y Yamada
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

6.  Functional analysis of human T cell subsets defined by monoclonal antibodies. III. Regulation of helper factor production by T cell subsets.

Authors:  Y Thomas; J Sosman; L Rogozinski; O Irigoyen; P C Kung; G Goldstein; L Chess
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

7.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

8.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man.

Authors:  P A Gatenby; G S Kansas; C Y Xian; R L Evans; E G Engleman
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

10.  Surface markers of cloned human T cells with various cytolytic activities.

Authors:  L Moretta; M C Mingari; P R Sekaly; A Moretta; B Chapuis; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.